Researchers who discovered a mechanism that prevents B cells from attacking the body’s own tissues in autoimmune diseases win ...

The potential elimination of lupus programs across government would undermine the incredible progress and significant ...

Inebilizumab-cdon was previously approved by the FDA for neuromyelitis optica spectrum disorder (NMOSD) in adults who are ...

Immunology is pivotal in addressing significant health challenges, from enhancing vaccine efficacy to identifying therapeutic targets for complex diseases.

Pericarditis recurrence in lupus is more likely — and has a dose-dependent relationship — with oral prednisone treatment, ...

Charles River Laboratories International, Inc. CRL and Valo Health, Inc. recently announced an advanced product candidate for the treatment of different forms of lupus and other autoimmune indications ...

Learn what to expect when you see a rheumatologist for the first time, with expert recommendations on how to get the most out ...

Women have a higher proportion of key immune cells between puberty and menopause, which may be linked to the sex hormone ...

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to ...

Three Husker students under the mentorship of Luwen Zhang, a leading University of Nebraska-Lincoln virologist, have achieved ...

The drug discovery pact between Charles River Laboratories, Valo Health and Flagship Pioneering is starting to bear fruit. | The drug discovery pact between Charles River Laboratories, Valo Health and ...